All Stories

  1. Association Between Achieving Inpatient Glycemic Control and Clinical Outcomes in Hospitalized Patients With COVID-19: A Multicenter, Retrospective Hospital-Based Analysis
  2. The Diabetes Technology Society Green Diabetes Initiative
  3. The Need for Precision Medicine to be Applied to Diabetes
  4. The Need to Change Regulatory Evaluation of Hypoglycemia in Trials of Diabetes Treatments
  5. The End of the Road for the YSI 2300 Analyzer: Where Do We Go Now?
  6. Barriers and Solutions to a Recently Noted Failure of Diabetes Care Outcomes to Improve From 2005 to 2016 in the United States
  7. Is Digital Health for Diabetes in an Investment Bubble?
  8. The First Recall of a Diabetes Device Because of Cybersecurity Risks
  9. Postmarket Surveillance of Blood Glucose Monitor Systems Is Needed for Safety of Subjects and Accurate Determination of Effectiveness in Clinical Trials of Diabetes Drugs and Devices
  10. Hemoglobinopathies and Hemoglobin A1c in Diabetes Mellitus
  11. The Need for Accuracy in Hemoglobin A1c Proficiency Testing: Why the Proposed CLIA Rule of 2019 Is a Step Backward
  12. The New FDA Real-World Evidence Program to Support Development of Drugs and Biologics
  13. The Expanding Role of Real-World Evidence Trials in Health Care Decision Making
  14. Behavioral Theory: The Missing Ingredient for Digital Health Tools to Change Behavior and Increase Adherence
  15. New Opportunities for Digital Health to Thrive
  16. Diabetes Technology Society Report on the FDA Digital Health Software Precertification Program Meeting
  17. A Milestone in Point of Care Capillary Blood Glucose Monitoring of Critically Ill Hospitalized Patients
  18. Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors
  19. Finding Real Value From Digital Diabetes Health: Is Digital Health Dead or in Need of Resuscitation?
  20. Standards for Medical Device Cybersecurity in 2018
  21. Smart Pens Will Improve Insulin Therapy
  22. Overcoming Barriers to Adoption of Digital Health Tools for Diabetes
  23. A Simplified Approach Using Rate of Change Arrows to Adjust Insulin With Real-Time Continuous Glucose Monitoring
  24. Digital Diabetes Congress 2017
  25. Now Is the Time for a Security and Safety Standard for Consumer Smartphones Controlling Diabetes Devices
  26. Fog Computing and Edge Computing Architectures for Processing Data From Diabetes Devices Connected to the Medical Internet of Things
  27. Insulin Pump Occlusions: For Patients Who Have Been Around the (Infusion) Block
  28. Meeting Report: The Fourth Artificial Pancreas Workshop: Testing and Adoption of Current and Emerging Technologies
  29. The Need for a Privacy Standard for Medical Devices That Transmit Protected Health Information Used in the Precision Medicine Initiative for Diabetes and Other Diseases
  30. Half-Unit Insulin Pens: Disease Management in Patients With Diabetes Who Are Sensitive to Insulin
  31. Digital Diabetes Communication
  32. Now Is the Time for a Cybersecurity Standard for Connected Diabetes Devices
  33. Telemedicine for Diabetes
  34. Telemedicine for Diabetes
  35. Development of the Diabetes Technology Society Blood Glucose Monitor System Surveillance Protocol
  36. PRIDE Statement on the Need for a Moratorium on the CMS Plan to Cite Hospitals for Performing Point-of-Care Capillary Blood Glucose Monitoring on Critically Ill Patients
  37. Accuracy and Injection Force of the Gla-300 Injection Device Compared With Other Commercialized Disposable Insulin Pens